Benaroya Research Institute Awarded $4.1 Million National Institutes of Health Grant to Study Regulatory T Cells’ Function in Immune System Homeostasis
Read More
Runner Completes “2 Half Marathons, 2 Coasts, 2 Days” in support of BRI and Autoimmune Disease Awareness
Read More
LITAF Protects Against Pore-Forming Protein–Induced Cell Death by Promoting Membrane Repair: Interview with Drs. Stefani & Lacy-Hulbert
Read More ➡
Benaroya Research Institute’s Steven F. Ziegler, PhD, Named 2024 Distinguished Fellow by the American Association of Immunologists
Read More
Benaroya Research Institute President Jane Buckner, MD, Receives 2024 American Association of Immunologists’ Steinman Award for Human Immunology Research
Read More
Protein LITAF Provides Resistance to Pore-Forming Toxin-Induced Cell Death
Read More
Science in Seattle: A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab
Read the publication ➡
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
Read More
BRI Investigator Alice Long, PhD, Interviewed on the Immunology Podcast
Read More
Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award
Read More
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
Read More
BRI Investigators Jane Buckner, MD, and Carmen Mikacenic, MD, Interviewed on the Arthritis Life Podcast
Read More
Researchers zoom in on new ways to view biomolecules in pathogens
Read More ➡
Vlad V. Simianu, MD, MPH, Appointed as Medical Director of Benaroya Research Institute’s Clinical Research Program
Read More
